|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02269 WUXI BIO
Nominal 
17.540 +0.200 (+1.153%) Ranking Overview
Ranking based on 11 research report(s)
Average Ranking 2.45
|
Strong Buy (1)
0
|
Buy (2)
6
|
Hold (3)
5
|
Sell (4)
0
|
Strong Sell (5)
0
|
Previous Financial Performance
| Financial Year | 12/2023 | EPS | 82.00 RMB (cts) | |
| Net Profit | 3,399.73 RMB (MIL) | DPS | 0.00 RMB (cts) |
Consolidation Estimation
| Financial Year | Profit / (Loss) (RMB (MIL)) |
EPS/ ((LPS)(RMB (cts)) |
DPS (RMB (cts)) |
Net Asset Value per Share (RMB) |
Highest (RMB (MIL)) |
Lowest (RMB (MIL)) |
| 2024 | 3,347.00 | 81.00 | 0 | -- | 5,094.10 | 2,731.00 |
| 2025 | 3,840.00 | 90.00 | 0 | -- | 5,729.10 | 2,655.00 |
| 2026 | 4,524.00 | 107.50 | 0 | -- | 6,547.70 | 3,569.00 |
Profit Estimation
| Profit Estimation | Profit / (Loss) (RMB (MIL)) |
EPS*/ (LPS) (RMB (cts)) |
DPS * (RMB (cts)) |
Broker | Ranking | Target Price* (HKD) |
Update Date | |
| 2024 | 3,818.53 | 90.00 | -- | JEFFERIES HK | Buy | 42.00 | 26/08/2024 | |
| 2024 | 3,352.00 | 81.00 | -- | MORGAN STANLEY | Overweight | 31.60 | 06/12/2024 | |
| 2024 | 3,347.00 | 77.00 | -- | CITIGROUP | Buy | 30.00 | 22/08/2024 | |
| 2024 | 3,219.00 | 115.00 | -- | CMB INT'L SEC | Buy | 22.88 | 12/12/2024 | |
| 2024 | 3,096.00 | 75.00 | -- | FIRST SHANGHAI SEC | Buy | 18.30 | 15/11/2024 | |
| 2024 | 5,094.10 | 120.00 | -- | GOLDMAN SACHS | Neutral | 16.60 | 23/08/2024 | |
| 2024 | 3,247.00 | 76.00 | -- | JP MORGAN | Neutral | 13.00 | 26/11/2024 | |
| 2024 | 3,361.00 | 81.00 | -- | CLSA | OutPerform | 12.60 | 23/08/2024 | |
| 2024 | 3,788.00 | 86.90 | -- | BOCOM | Neutral | 12.30 | 22/08/2024 | |
| 2024 | 3,238.00 | 78.00 | -- | UBS | Neutral | 11.50 | 23/08/2024 | |
| 2024 | 2,731.00 | 89.00 | -- | CHINA MERCHANTS | Hold | 10.00 | 22/08/2024 | |
| 2025 | 4,666.90 | 110.00 | -- | JEFFERIES HK | -- | -- | 26/08/2024 | |
| 2025 | 3,612.00 | 87.00 | -- | MORGAN STANLEY | -- | -- | 06/12/2024 | |
| 2025 | 3,569.00 | 82.10 | -- | CITIGROUP | -- | -- | 22/08/2024 | |
| 2025 | 3,947.00 | 128.00 | -- | CMB INT'L SEC | -- | -- | 12/12/2024 | |
| 2025 | 3,503.00 | 85.00 | -- | FIRST SHANGHAI SEC | -- | -- | 15/11/2024 | |
| 2025 | 5,729.10 | 135.00 | -- | GOLDMAN SACHS | -- | -- | 23/08/2024 | |
| 2025 | 3,840.00 | 90.00 | -- | JP MORGAN | -- | -- | 26/11/2024 | |
| 2025 | 4,091.00 | 98.00 | -- | CLSA | -- | -- | 23/08/2024 | |
| 2025 | 4,629.00 | 106.10 | -- | BOCOM | -- | -- | 22/08/2024 | |
| 2025 | 3,400.00 | 82.00 | -- | UBS | -- | -- | 23/08/2024 | |
| 2025 | 2,655.00 | 88.00 | -- | CHINA MERCHANTS | -- | -- | 22/08/2024 | |
| 2026 | 6,247.31 | 147.00 | -- | JEFFERIES HK | -- | -- | 26/08/2024 | |
| 2026 | 4,152.00 | 100.00 | -- | MORGAN STANLEY | -- | -- | 06/12/2024 | |
| 2026 | 3,653.00 | 84.00 | -- | CITIGROUP | -- | -- | 22/08/2024 | |
| 2026 | 4,582.00 | 145.00 | -- | CMB INT'L SEC | -- | -- | 12/12/2024 | |
| 2026 | 3,989.00 | 97.00 | -- | FIRST SHANGHAI SEC | -- | -- | 15/11/2024 | |
| 2026 | 6,547.70 | 154.00 | -- | GOLDMAN SACHS | -- | -- | 23/08/2024 | |
| 2026 | 4,518.00 | 106.00 | -- | JP MORGAN | -- | -- | 26/11/2024 | |
| 2026 | 4,530.00 | 109.00 | -- | CLSA | -- | -- | 23/08/2024 | |
| 2026 | 5,595.00 | 128.30 | -- | BOCOM | -- | -- | 22/08/2024 | |
| 2026 | 3,569.00 | 86.00 | -- | UBS | -- | -- | 23/08/2024 | |
| Remarks: | Average rating ranges from 1 to 5. The lower the figure, the higher the rating and the vice versa. |
| *EPS, DPS and Estimated Price would be adjusted upon Consolidation, Split and Bonus Issue | |
| Real time quote last updated: 30/12/2024 11:09 | |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 1,499,080 |
| %Change | -33.864% |
| EPS / (LPS) | RMB 0.370 |
| NBV Per Share (¥) | RMB 9.789 |